MAXNERVA TECH(01037): BOCOM International appointed as independent financial adviser
MAXNERVA TECH(01037) announces that BOCOM International (a licensed corporation permitted under the Securities and Futures Ordinance to conduct Type 1 (dealing in securities) and Type 6 (advising on corporate finance) regulated activities) has been appointed as the independent financial adviser to provide advice to the independent board committee regarding the offers, in particular as to whether the share offer is fair and reasonable and whether to accept it, and to provide a recommendation to the independent shareholders, as well as to provide a recommendation to the option holders regarding its view on the option offer. The appointment of BOCOM International has been approved by the independent board committee in accordance with Rule 2.1 of the Takeovers Code.
MAXNERVA TECH (01037) announces that BOCOM International (BOCOM International, a licensed corporation permitted under the Securities and Futures Ordinance to carry on Type 1 (dealing in securities) and Type 6 (advising on corporate finance) regulated activities) has been appointed as the independent financial adviser to provide advice to the independent board committee in respect of the offers, in particular, as to whether the share offer is fair and reasonable and whether to accept it, to provide a recommendation to the independent shareholders, and to provide a recommendation to the option holders on its view of the share option offer. The appointment of BOCOM International has been approved by the independent board committee in accordance with Rule 2.1 of the Takeovers Code.
Related Articles

CHAOJU EYE CARE (02219) repurchased 40,500 shares for approximately HK$99,100 on September 17.
Jiangsu Cowin Biotech (688426.SH) granted 3.1 million restricted shares to 122 incentive recipients.

ZYLOXTB (02190) repurchased 55,500 shares for HK$1.149 million on September 17.
CHAOJU EYE CARE (02219) repurchased 40,500 shares for approximately HK$99,100 on September 17.

Jiangsu Cowin Biotech (688426.SH) granted 3.1 million restricted shares to 122 incentive recipients.
ZYLOXTB (02190) repurchased 55,500 shares for HK$1.149 million on September 17.

RECOMMEND





